This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

Infosys accuses Cognizant of anticompetitive practices in US trade secret battle

( January 10, 2025, 21:26 GMT | Official Statement) -- MLex Summary: India's leading software giant Infosys has accused US tech giant Cognizant of leveraging monopoly power to obstruct competition against its healthcare platform, Helix. In a countersuit filed with the US District Court of Northern District of Texas, Dallas division, in January 2025, Infosys sued Cognizant, alleging an anticompetitive scheme to dominate the healthcare payor software and related IT services markets by hindering Helix's market entry. This development follows an ongoing legal battle that began in August 2024 as a trade secret suit between the two tech rivals filed in the US and has now expanded to include antitrust issues.The document filed with the US District Court is attached....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents